These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 21918510)
21. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E; J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290 [TBL] [Abstract][Full Text] [Related]
22. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317 [TBL] [Abstract][Full Text] [Related]
23. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network. Wiederkehr D; Berenson K; Casciano R; Stern L; Makenbaeva D; Mozaffari E; Lamerato L; Corbelli J Curr Med Res Opin; 2009 Sep; 25(9):2317-25. PubMed ID: 19635042 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770 [TBL] [Abstract][Full Text] [Related]
25. Comparison of efficacy and safety of a standard versus a loading dose of clopidogrel for acute myocardial infarction in patients ≥ 75 years of age (from the FAST-MI registry). Puymirat E; Aïssaoui N; Coste P; Dentan G; Bataille V; Drouet E; Mulak G; Carrié D; Blanchard D; Simon T; Danchin N Am J Cardiol; 2011 Sep; 108(6):755-9. PubMed ID: 21726837 [TBL] [Abstract][Full Text] [Related]
26. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction. Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347 [TBL] [Abstract][Full Text] [Related]
27. Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI. Park KW; Park JJ; Kang J; Jeon KH; Kang SH; Han JK; Lee SE; Yang HM; Lee HY; Kang HJ; Koo BK; Oh BH; Park YB; Kim HS PLoS One; 2013; 8(2):e52779. PubMed ID: 23418418 [TBL] [Abstract][Full Text] [Related]
28. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting. L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931 [TBL] [Abstract][Full Text] [Related]
29. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E; Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504 [TBL] [Abstract][Full Text] [Related]
30. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry). Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U; Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027 [TBL] [Abstract][Full Text] [Related]
31. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009 [TBL] [Abstract][Full Text] [Related]
32. Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients. Yang J; Zhou JS; Tan J; He BS; Zou JJ Pharmazie; 2012 Dec; 67(12):1026-9. PubMed ID: 23346768 [TBL] [Abstract][Full Text] [Related]
33. The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population. Kallel A; Sediri Y; Sbaï MH; Mourali MS; Feki M; Elasmi M; Taieb SH; Sanhaji H; Souheil O; Mechmeche R; Jemaa R; Kaabachi N Clin Biochem; 2010 Dec; 43(18):1461-3. PubMed ID: 20833162 [TBL] [Abstract][Full Text] [Related]
34. Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants. Martínez-Quintana E; Medina-Gil JM; Rodríguez-González F; Garay-Sánchez P; Limiñana JM; Saavedra P; Tugores A J Clin Pharmacol; 2014 Aug; 54(8):843-9. PubMed ID: 24504666 [TBL] [Abstract][Full Text] [Related]
35. Relationship of paraoxonase-1 Q192R genotypes and in-stent restenosis and re-stenting in Chinese patients after coronary stenting. Ma W; Liang Y; Zhu J; Chen T; Feng G; Yang Y; Liu X; Wang X Atherosclerosis; 2016 Aug; 251():305-310. PubMed ID: 27450784 [TBL] [Abstract][Full Text] [Related]
36. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. Hochholzer W; Trenk D; Bestehorn HP; Fischer B; Valina CM; Ferenc M; Gick M; Caputo A; Büttner HJ; Neumann FJ J Am Coll Cardiol; 2006 Nov; 48(9):1742-50. PubMed ID: 17084243 [TBL] [Abstract][Full Text] [Related]
38. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176 [TBL] [Abstract][Full Text] [Related]
39. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. van Himbergen TM; van der Schouw YT; Voorbij HA; van Tits LJ; Stalenhoef AF; Peeters PH; Roest M Atherosclerosis; 2008 Aug; 199(2):408-14. PubMed ID: 18164014 [TBL] [Abstract][Full Text] [Related]
40. Predicting clopidogrel response using DNA samples linked to an electronic health record. Delaney JT; Ramirez AH; Bowton E; Pulley JM; Basford MA; Schildcrout JS; Shi Y; Zink R; Oetjens M; Xu H; Cleator JH; Jahangir E; Ritchie MD; Masys DR; Roden DM; Crawford DC; Denny JC Clin Pharmacol Ther; 2012 Feb; 91(2):257-63. PubMed ID: 22190063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]